Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2890639

Cc1onc(-c2ccccc2)c1NC(=O)NCC(N)=O.O=C(O)C(F)(F)F

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.63
MAPT P10636 3/20 0.51
ALDH1A1 P00352 3/20 0.49
NPSR1 Q6W5P4 1/20 0.47
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 1/20 0.46
KDM4E B2RXH2 1/20 0.46
THRB P10828 1/20 0.45
SCN9A Q15858 2/20 0.44
TSHR P16473 2/20 0.43
HTT P42858 1/20 0.43
PLA2G1B P04054 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
SCN5A Q14524 1/20 0.43
IDH1 O75874 1/20 0.43
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2890644 0.87 NTRK1 (0.63) NTRK1MAPTALDH1A1NPSR1MEN1
SCHEMBL2890642 0.82 NTRK1 (0.66) NTRK1MAPTALDH1A1NPSR1GAA
SCHEMBL16585459 0.77 NTRK1 (1.00) NTRK1MAPTALDH1A1NPSR1KDM4E
SCHEMBL5527223 0.77 MEN1 (0.61) NTRK1MAPTALDH1A1NPSR1MEN1
SCHEMBL1912284 0.77 NTRK1 (0.61) NTRK1MAPTALDH1A1NPSR1MEN1
SCHEMBL17790727 0.76 MAPT (0.60) NTRK1MAPTALDH1A1NPSR1MEN1
SCHEMBL4029460 0.75 NPSR1 (0.61) NTRK1MAPTALDH1A1NPSR1MEN1
SCHEMBL18007209 0.75 NTRK1 (0.74) NTRK1MAPTALDH1A1NPSR1MEN1
SCHEMBL16585889 0.75 NTRK1 (0.73) NTRK1MAPTALDH1A1NPSR1KDM4E
SCHEMBL18015478 0.75 NTRK1 (1.00) NTRK1MAPTALDH1A1NPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8258141-B2 Organic compounds NOVARTIS AG (CH) 2012-09-04 US disclosed
US-20100286126-A1 Organic Compounds NOVARTIS AG (CH) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286126-A1 Organic Compounds CYP3A43, SLCO1B3, CYP2C19 NTRK1 3668/4885MAPT 1870/4885ALDH1A1 166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.